Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 May 2020

Hu Jing, Shen Junwei, Sun Jing

Abstract excerpt

The increasing incidence rate and decreasing patients' five-year survival rate for endometrial cancer (EC) in recent decades highlight the necessity for further investigation of the molecular characteristics involved in cancer initiation and progression. In this study, we found that the pathways associated with mitotic cell cycle were enriched in primary EC samples versus normal endometrial samples through...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to Cyclin-Dependent Kinase 4
Share to E2F Transcription Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Molecular Targeted Therapy

Share to Retinoblastoma Protein

Share to Transcriptional Activation

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 32032891
DOI: 10.1016/j.biopha.2020.109870

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.PMID 32032891Read ↗

Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial CarcinomaSemantic proximity Read ↗

Study on the regulatory mechanism of EAF2 in the microenvironment of cervical cancerSemantic proximity Read ↗

Expression and gene regulation network of EAF2 in cervical cancer based on data miningSemantic proximity Read ↗

Systematic Analysis of the Clinical Relevance of Cell Division Cycle Associated Family in Endometrial CarcinomaSemantic proximity Read ↗

The role of E2F2 in cancer progression and its value as a therapeutic targetSemantic proximity Read ↗

Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma.Semantic proximity Read ↗

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survivalSemantic proximity Read ↗

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune MicroenvironmentSemantic proximity Read ↗

An Update on the Potential Roles of E2F Family Members in Colorectal CancerSemantic proximity Read ↗

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancerSemantic proximity Read ↗

Identification of Candidate Biomarkers Associated With the Diagnosis and Prognosis of Endometrial Cancer ：A Bioinformatics Analysis IdentifiesSemantic proximity Read ↗

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.